Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
N/A
3,600 Added 120.0%
6,600 $8,000
Q2 2024

Aug 14, 2024

BUY
N/A
1,400 Added 87.5%
3,000 $3,000
Q1 2024

May 15, 2024

BUY
N/A
1,600 New
1,600 $2,000
Q2 2023

Aug 14, 2023

SELL
N/A
-2,700 Reduced 17.53%
12,700 $16,000
Q1 2023

May 15, 2023

SELL
N/A
-120,800 Reduced 88.69%
15,400 $19,000
Q4 2022

Feb 14, 2023

SELL
N/A
-4,400 Reduced 3.13%
136,200 $175,000
Q3 2022

Nov 14, 2022

BUY
$1.29 - $2.52 $19,995 - $39,060
15,500 Added 12.39%
140,600 $187,000

Others Institutions Holding CRTX

About Cortexyme, Inc.


  • Ticker CRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,150,800
  • Market Cap $70.5M
More about CRTX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.